Chiasma Inc.

Chiasma Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
24.39 M
Public Float
12.61 M
Chiasma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.35
Market Cap
$187.51 M
Shares Outstanding
31.73 M
Public Float
13.56 M

Profile

Address
460 Totten Pond Road
Waltham Massachusetts 02451
United States
Employees -
Website http://www.chiasmapharma.com
Updated 07/08/2019
Chiasma, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The company's Transient Permeability Enhancer (TPE) technology platform, seeks to develop oral medications.

Financials

View All

Mark J. Fitzpatrick
President, Chief Executive Officer & Director
Roni Mamluk
Director